Γαληνός - Βιβλιογραφία - TAMIFLU Powder for oral suspension

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Name of the medicinal product

Tamiflu 6 mg/ml powder for oral suspension.

Qualitative and quantitative composition

Each ml of reconstituted suspension contains oseltamivir phosphate equivalent to 6 mg of oseltamivir. One bottle of
reconstituted suspension (65 ml) contains 390 mg of oseltamivir. Excipients with known ...

Pharmaceutical form

Powder for oral suspension. The powder is a granulate or clumped granulate with a white to light yellow colour.

Therapeutic indications

Treatment of influenza Tamiflu is indicated in adults and children including full term neonates who present with
symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy ...

Posology and method of administration

Posology Tamiflu suspension and Tamiflu hard capsules are bioequivalent formulations. 75 mg doses can be
administered as either one 75 mg capsule or one 30 mg capsule plus one 45 mg capsule or by administering ...

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Special warnings and precautions for use

Oseltamivir is effective only against illness caused by influenza viruses. There is no evidence for efficacy of
oseltamivir in any illness caused by agents other than influenza viruses (see section 5.1). ...

Interaction with other medicinal products and other forms of interaction

Pharmacokinetic properties of oseltamivir, such as low protein binding and metabolism independent of the CYP450
and glucuronidase systems (see section 5.2), suggest that clinically significant drug interactions ...

Fertility, pregnancy and lactation

Pregnancy Influenza is associated with adverse pregnancy and foetal outcomes, with a risk of major congenital
malformations, including congenital heart defects. A large amount of data on oseltamivir exposure ...

Effects on ability to drive and use machines

Tamiflu has no influence on the ability to drive and use machines.

Undesirable effects

Summary of the safety profile The overall safety profile of Tamiflu is based on data from 6049 adult/adolescent and
1473 paediatric patients treated with Tamiflu or placebo for influenza, and on data from ...

Overdose

You might also like